Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Collier

Showing results (331-340 of 508) with videos related to

Pageof 51
Sort By:
The Journal of Antimicrobial Chemotherapy|August 28, 2014
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202Charles S Venuto, Katie Mollan, Qing Ma, et al.
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
Journal of the International Association of Providers of AIDS Care|March 9, 2021
"Lighten This Burden of Ours": Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal KenyaJane M Simoni, Kristin Beima-Sofie, George Wanje, et al.
AJNR. American Journal of Neuroradiology|July 11, 1992
Prospective cerebral MR study of HIV seropositive and seronegative men: correlation of MR findings with neurologic, neuropsychologic, and cerebrospinal fluid analysisW A Cohen, K R Maravilla, R Gerlach, et al.
Molecular Ecology|November 18, 2018
The fate of genes that cross species boundaries after a major hybridization event in a natural mosquito populationMark J Hanemaaijer, Travis C Collier, Allison Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 proteinE L Cooney, M J McElrath, L Corey, et al.
The Journal of Infectious Diseases|August 19, 2000
Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333M F Para, D V Glidden, R W Coombs, et al.
AIDS (London, England)|August 28, 2007
The prevalence and incidence of neurocognitive impairment in the HAART eraKevin R Robertson, Marlene Smurzynski, Thomas D Parsons, et al.
AIDS Care|January 25, 2021
Poor quality of life and incomplete self-reported adherence predict second-line ART virological failure in resource-limited settingsThiago S Torres, Linda J Harrison, Alberto M La Rosa, et al.
AIDS (London, England)|January 27, 2007
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimenMargaret A Fischl, Ann C Collier, A Lisa Mukherjee, et al.
Pageof 51

Showing results (331-340 of 508) with videos related to

Sort By:
Pageof 51
The Journal of Antimicrobial Chemotherapy|August 28, 2014
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202Charles S Venuto, Katie Mollan, Qing Ma, et al.
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
Journal of the International Association of Providers of AIDS Care|March 9, 2021
"Lighten This Burden of Ours": Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal KenyaJane M Simoni, Kristin Beima-Sofie, George Wanje, et al.
AJNR. American Journal of Neuroradiology|July 11, 1992
Prospective cerebral MR study of HIV seropositive and seronegative men: correlation of MR findings with neurologic, neuropsychologic, and cerebrospinal fluid analysisW A Cohen, K R Maravilla, R Gerlach, et al.
Molecular Ecology|November 18, 2018
The fate of genes that cross species boundaries after a major hybridization event in a natural mosquito populationMark J Hanemaaijer, Travis C Collier, Allison Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 proteinE L Cooney, M J McElrath, L Corey, et al.
The Journal of Infectious Diseases|August 19, 2000
Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333M F Para, D V Glidden, R W Coombs, et al.
AIDS (London, England)|August 28, 2007
The prevalence and incidence of neurocognitive impairment in the HAART eraKevin R Robertson, Marlene Smurzynski, Thomas D Parsons, et al.
AIDS Care|January 25, 2021
Poor quality of life and incomplete self-reported adherence predict second-line ART virological failure in resource-limited settingsThiago S Torres, Linda J Harrison, Alberto M La Rosa, et al.
AIDS (London, England)|January 27, 2007
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimenMargaret A Fischl, Ann C Collier, A Lisa Mukherjee, et al.
Pageof 51